Logo.png
Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight
23 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight   The increasing...
Logo.png
ESMO 2023 Coverage: Get real time insights and analysis with DelveInsight
20 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 20, 2023 (GLOBE NEWSWIRE) -- ESMO 2023 Coverage: Get real time insights and analysis with DelveInsight The ESMO conference stands as a pivotal event in the oncology sphere,...
Logo.png
Treatment-Resistant Depression Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Navitor, Supernus, Novartis, Relmada, Beckley Psytech, COMPASS, Axsome, Celon Pharma
19 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Treatment-Resistant Depression Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Navitor, Supernus,...
Logo.png
Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular Imaging, Merz, Vasopharm, Pinteon, Omniscient Neurotechnology
18 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular...
Logo.png
Schizophrenia Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Otsuka, Boehringer Ingelheim, Merck, Sunivion, PsychoGenics, Neurocrine Biosciences, Takeda, Lyndra, Cerevel
17 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Schizophrenia Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Otsuka, Boehringer Ingelheim,...
Logo.png
Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight
16 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight The overall...
Logo.png
Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight
12 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight  ...
Logo.png
Diabetic Retinopathy Market to Register Incremental Growth by 2032, Asserts DelveInsight | Leading Companies in the Market - Opthea, Regenxbio, Kodiak, Ocuphire, Eisai, Apexian, Oculis, Bayer, Novartis, Allegro
11 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Diabetic Retinopathy Market to Register Incremental Growth by 2032, Asserts DelveInsight | Leading Companies in the Market - Opthea, Regenxbio,...
Logo.png
Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight
10 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight  The emergence of new products...
Logo.png
Hemophilia A Market to Exhibit Growth at a Remarkable CAGR During the Study Period (2019-2032) | DelveInsight
09 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Hemophilia A Market to Exhibit Growth at a Remarkable CAGR During the Study Period (2019-2032) | DelveInsight  The current therapeutic landscape...